Phaarmasia Ltd. engages in the manufacture of pharmaceutical products. The company is headquartered in Hyderabad, Telangana. The firm is primarily engaged in the manufacturing and sale of oral contraceptive pills (OCP's). The company markets oral contraceptive tablets with various therapeutic dosage combinations along with iron tablets for Ministry of Health & Family Welfare and for Exports. Its products categories include hormone products and herbal products. Its hormone products include Medroxyprogesterone Acetate Tablets, Cabergoline Tablets, Clomiphene Citrate Tablets, Progesterone Tablet, Levonorgestrel Tablet, Fluoxymesterone tablets, Liothyronine Sodium tablets, Chlorodehydromethyltestosterone Tabs, Liothyronine sodium tablets, and Oxandrolone tablets USP. Its injectables include Methenolone Enanthate Injection, Drostanolone, Testosterone and Trenbolone Inj, and Stanozolol Cypionate Inj. Its herbal products include Smyle Herbal Toothpaste, Smyle Cough & Sore Throat Reliver, and Smyle Mouth Ulcer Gel.
Loading chart…
Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:
The headline call - descriptive label, conviction, and the synthesis behind it.
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Forensic and governance risk pointers, severity-ranked.
Solvency and earnings-quality score.
Quarter-by-quarter earnings-call briefs - what changed and why.